We seek support for our studies of an inbred colony of allergic dogs, now in its fifth generation. These dogs are given live viral vaccines at the time of immunization with ragweed pollen antigen in infancy; within weeks they develop specific IgE antibodies. Upon maturity, they experience antigen-induced immediate and late-phase reactions in airways, skin and nose, comparable to allergic human patients. These unique dogs present an extraordinary opportunity to study the pathogenesis of allergic reactions by immunopharmacologic, biochemical, physiologic, and anatomic methods.
Specific aims are to assess the anatomic and biochemical responses to immunologic and nonimmunologic stimuli on atypical and typical mast cells and on circulating and resident inflammatory cells (granulocytes, platelets, mononuclear cells) in skin and airways; and assess the contribution of these cells to early- and late-phase inflammatory responses and to increased physiologic responses to histamine and acetylcholine in skin and airways, respectively. We intend to define the anatomic and functional characteristics of cultured dog airway mast cells in vitro and compare them to subsets of mast cells in dog skin in vivo (using serial skin biopsies and surface chambers to collect secreted mediators) in response to nonimmunologic and immunologic stimuli. We shall examine the role of different types of mast cells in skin and airways in triggering inflammatory responses and the roles of neutrophils and eosinophils in production of increased skin and airway responsiveness following exposure to antigen. Hydroxyurea and poly- and monoclonal antisera to neutrophils and eosinophils will be used to deplete such cells so that responsiveness can be compared in presence or absence of these cells. Drugs, humoral agents, and transfused IgG antibodies will be given to try to modulate these responses in skin and airways. Hopefully, these results will suggest new approaches that can be applied in future studies to prevent or treat diseases in human allergic patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015233-08
Application #
3126081
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1979-05-01
Project End
1989-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
8
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Gold, W M; Lazarus, S C (1991) Mast cells and cell-to-cell interactions in airways. Am Rev Respir Dis 143:S61-3
Mayeno, A N; Lin, F; Foote, C S et al. (1990) Characterization of ""peak E,"" a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250:1707-8
Rubinstein, I; Nadel, J A; Graf, P D et al. (1990) Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs. J Clin Invest 86:555-9
Becker, A B; Chung, K F; Aizawa, H et al. (1989) Inhibition of the cutaneous response to antigen by a thromboxane-synthetase inhibitor (OKY-046) in allergic dogs. J Allergy Clin Immunol 84:206-13
Reiss, T F; Rubinstein, I; Emery, D L et al. (1989) Local mediator release after antigen challenge of a bronchial segment in allergic dogs. Am J Physiol 257:L366-72
Becker, A B; Chung, F; McDonald, D M et al. (1988) Cutaneous allergic response in atopic dogs: relationship of cellular and histamine responses. J Allergy Clin Immunol 81:441-8
Chung, K F; Osborne, M L; Corrales, R J et al. (1987) Histamine release and circulating cells after antigen inhalation in allergic dogs. J Appl Physiol 62:253-8
Becker, A B; Chung, K F; McDonald, D M et al. (1986) Cutaneous mast cell heterogeneity: response to antigen in atopic dogs. J Allergy Clin Immunol 78:937-42
Gold, W M (1986) Mechanisms of antigen-induced reactions in skin and lung. Respiration 50 Suppl 2:42-56
Chung, K F; Aizawa, H; Becker, A B et al. (1986) Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis 134:258-61

Showing the most recent 10 out of 14 publications